Want to join the conversation?
$LEN 2Q15 Call – Stuart, CEO: Production deficit of both rental and for-sale home relative to the need of for-housing in US continues to create pent-up demand against the very limited supply. Regulatory environment for mortgages remains challenging and limits the number of entrance for the for-sale market.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.